Autolus Therapeutics plc SEC filings AUTL
Autolus Therapeutics plc has 336 filings in SEC EDGAR's recent list, going back to Feb 9, 2018. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 22, 2026 | — |
| S-3 | Shelf registration | Sep 14, 2026 | — |
| S-3 | Shelf registration | Apr 13, 2026 | — |
| S-3 | Shelf registration | Apr 13, 2026 | — |
| 424B3 | Prospectus | Jan 26, 2026 | — |
| 424B3 | Prospectus | Jan 12, 2026 | — |
| 424B3 | Prospectus | Dec 2, 2025 | — |
| S-8 | Employee stock plan registration | Nov 18, 2025 | — |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Jun 30, 2025 | — |
| 424B3 | Prospectus | May 30, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| S-1 | Registration statement | May 8, 2025 | — |
| POS AM | Filing | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Nov 14, 2024 | — |
| S-3ASR | Automatic shelf registration | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Feb 9, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 8, 2024 | — |
| S-8 | Employee stock plan registration | Nov 3, 2023 | — |
| S-8 | Employee stock plan registration | Aug 7, 2023 | — |
| F-6EF | Filing | Mar 1, 2023 | — |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| 424B5 | Prospectus supplement | Dec 8, 2022 | — |
| 424B3 | Prospectus | May 18, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | May 4, 2022 | — |
| 424B3 | Prospectus | May 3, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 15, 2022 | — |
| F-6EF | Filing | Nov 9, 2021 | — |
| 424B5 | Prospectus supplement | Aug 19, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 5, 2021 | — |
| 424B5 | Prospectus supplement | Feb 11, 2021 | — |
| 424B5 | Prospectus supplement | Feb 8, 2021 | — |
| 424B5 | Prospectus supplement | Sep 18, 2020 | — |
| 424B5 | Prospectus supplement | Jan 24, 2020 | — |
| 424B5 | Prospectus supplement | Jan 22, 2020 | — |
| 424B5 | Prospectus supplement | Jul 24, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 17, 2019 | — |
| 424B4 | Prospectus | Apr 11, 2019 | — |
| F-1MEF | Filing | Apr 10, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Apr 8, 2019 | — |
| S-8 | Employee stock plan registration | Jul 31, 2018 | — |
| 424B4 | Prospectus | Jun 22, 2018 | — |
| F-1MEF | Filing | Jun 21, 2018 | — |
| F-6/A | Filing | Jun 19, 2018 | — |
| F-1/A | Filing | Jun 19, 2018 | — |
| F-6/A | Filing | Jun 19, 2018 | — |
| F-1/A | Filing | Jun 8, 2018 | — |
| F-1/A | Filing | May 10, 2018 | — |
| F-6 | Filing | May 10, 2018 | — |
| F-1 | Registration statement (foreign issuer) | May 7, 2018 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AUTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- London, United Kingdom
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1730463
- Former names
- Autolus Therapeutics Ltd (until Jun 8, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.